Ignite Creation Date:
2025-12-25 @ 12:19 AM
Ignite Modification Date:
2025-12-25 @ 10:22 PM
Study NCT ID:
NCT01078558
Status:
COMPLETED
Last Update Posted:
2019-07-05
First Post:
2010-03-01
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Belgian Registry of HUMIRA® (Adalimumab) in Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis ( ProAct )
Sponsor:
AbbVie (prior sponsor, Abbott)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-05-13
Start Date Type:
ACTUAL
Primary Completion Date:
2018-01-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-01-11
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-01
First Submit QC Date:
None
Study First Post Date:
2010-03-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-01-09
Results First Submit QC Date:
None
Results First Post Date:
2019-07-05
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-15
Last Update Post Date:
2019-07-05
Last Update Post Date Type:
ACTUAL